Journal of Clinical Endocrinology & Metabolism, Vol 80, 2149-2153, Copyright © 1995 by Endocrine Society

ARTICLES

Molecular study of the 5 alpha-reductase type 2 gene in three European families with 5 alpha-reductase deficiency

C Boudon, S Lumbroso, JM Lobaccaro, M Szarras-Czapnik, TE Romer, P Garandeau, P Montoya and C Sultan
Centre de Recherches de l'Institut National de la Sante et de la Recherche Medicale, INSERM, Montpellier, France.

The molecular basis of 5 alpha-reductase (5 alpha R) deficiency was investigated in four patients from three European families. In the French family, the first patient was raised as a female, and gonadectomy was performed before puberty. The second sibling, also raised as female, differed in that gonadal removal was performed after the onset of pubertal masculinization. The other two patients, both from Polish families, developed masculinization of external genitalia during puberty. All patients developed a female sexual identity. In all cases, no known consanguinity or family history of 5 alpha R deficiency was reported. The genomic DNAs of the patients were sequenced after polymerase chain reaction amplification of the five exons of the 5 alpha R type 2 gene. We found two homozygous mutations responsible for glutamine to arginine and histidine to arginine substitution in families 1 and 3, respectively. In family 2, we found a heterozygous mutation responsible for an asparagine to serine substitution at position 193. The glutamine/arginine 126 mutation in the French family was previously reported in a Creole ethnic group, and the Polish histidine/arginine 231 mutation was previously reported in a patient from Chicago. Moreover, all of the mutations created new restriction sites, which were used to determine the kindred carrier status in the three families. Because 5 alpha R deficiency is known to be a heterogenous disease in terms of clinical and biochemical expression, our data suggest that molecular biology analysis of the type 2 gene could be an essential step in diagnosing 5 alpha R deficiency.

This article has been cited by other articles:

				M. Fernandez-Cancio, M. Nistal, R. Gracia, M. A. Molina, J. A. Tovar, C. Esteban, A. Carrascosa, and L. Audi Compound Heterozygous Mutations in the SRD5A2 Gene Exon 4 in a Male Pseudohermaphrodite Patient of Chinese Origin J Androl, May 1, 2004; 25(3): 412 - 416. [Abstract] [Full Text] [PDF]

				G. Sasaki, T. Ogata, T. Ishii, K. Kosaki, S. Sato, K. Homma, T. Takahashi, T. Hasegawa, and N. Matsuo Micropenis and the 5{alpha}-Reductase-2 (SRD5A2) Gene: Mutation and V89L Polymorphism Analysis in 81 Japanese Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3431 - 3436. [Abstract] [Full Text] [PDF]

				A. Nordenskjöld and S.-A. Ivarsson Molecular Characterization of 5{alpha}-Reductase Type 2 Deficiency and Fertility in a Swedish Family J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3236 - 3238. [Abstract] [Full Text]